Takashi Inozume

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Alexander Eggermont, Christian U. Blank, Mario Mandalà et al. · The Lancet Oncology · 2021 · 364 citations · Full text

Surgical Oncology, Medicine, Melanoma +8

Selection of CD8+PD-1+ Lymphocytes in Fresh Human Melanomas Enriches for Tumor-reactive T Cells

Takashi Inozume, Ken‐ichi Hanada, Qiong J. Wang et al. · Journal of Immunotherapy · 2010 · 223 citations · Full text

Immunology, Immune Regulation, Immunoediting +21

Melanoma Cells Control Antimelanoma CTL Responses via Interaction between TIGIT and CD155 in the Effector Phase

Takashi Inozume, Tomonori Yaguchi, Junpei Furuta et al. · Journal of Investigative Dermatology · 2015 · 175 citations · Full text

Cancer Immunosurveillance, Effector Phase, Melanoma +6

Immune evasion through mitochondrial transfer in the tumour microenvironment

Hideki Ikeda, Katsushige Kawase, Tatsuya Nishi et al. · Nature · 2025 · 166 citations · Full text

PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes

Joji Nagasaki, Takashi Inozume, Nicolas Sax et al. · Cell Reports · 2022 · 104 citations · Full text